NL-OMON54194招募中2 期
Open, Randomized, Active Comparator-controlled, Multi-Center Study to Evaluate Safety and Efficacy of IBsolvMIR® in Islet Transplantation - IBsolvMIR in islet transplantation
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- TIKOMED AB
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •Complicated type1 diabetes, either with a previous kidney transplantation or
- •with severe hypoglycemia, waitlisted for allogeneic islet transplantation
排除标准
- •- Patients ineligible for islet transplant
- •- Patients with coagulation disorders
- •- Patients with prior organ transplants other than a kidney graft and/or
- •islets. A previous pancreas transplant can be accepted if it failed within the
- •first week due to thrombosis and the graft was removed
研究者
相似试验
进行中（未招募）
1 期
A study to evaluate safety and efficacy of IBsolvMIR® in transplantation of insulin-producing cells to patients with severe diabetesMedDRA version: 21.1Level: LLTClassification code 10045228Term: Type I diabetes mellitusSystem Organ Class: 100000004861Type 1 DiabetesEUCTR2016-001867-35-NOTikoMed AB18
进行中（未招募）
1 期
A study to evaluate safety and efficacy of IBsolvMIR® in transplantation of insulin-producing cells to patients with severe diabetesMedDRA version: 21.1Level: LLTClassification code 10045228Term: Type I diabetes mellitusSystem Organ Class: 100000004861Type 1 DiabetesEUCTR2016-001867-35-SETikoMed AB
招募中
1 期
A study to evaluate safety and efficacy of IBsolvMIR® in transplantation of insulin-producing cells to patients with severe diabetesType 1 DiabetesEUCTR2016-001867-35-NLTikoMed AB18
进行中（未招募）
不适用
A Phase 2 Study to Determine the Safety and Effectiveness of Multiple Doses of ISIS 416858 Injected Subcutaneously to Patients Undergoing Total Knee ArthroplastyProphylaxis of venous thromboembolism (VTE) in patients undergoing total knee arthroplasty (TKA)MedDRA version: 16.1Level: LLTClassification code 10049909Term: Venous thromboembolism prophylaxisSystem Organ Class: 100000004865EUCTR2012-001836-72-BGIsis Pharmaceuticals, Inc.400
进行中（未招募）
不适用
A Phase 2 Study to Determine the Safety and Effectiveness of Multiple Doses of ISIS 416858 Injected Subcutaneously to Patients Undergoing Total Knee ArthroplastyProphylaxis of venous thromboembolism (VTE) in patients undergoing total knee arthroplasty (TKA)MedDRA version: 14.1Level: LLTClassification code 10049909Term: Venous thromboembolism prophylaxisSystem Organ Class: 100000004865EUCTR2012-001836-72-LVIsis Pharmaceuticals, Inc.400